NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab
Alfredomaria Lurati, Luca Bertani, Mariagrazia Marrazza, Katia Angela Re, Daniela Bompane, Magda ScarpelliniRheumatology Unit, Fornaroli Hospital, Magenta, ItalyPurpose: The relationship between antiCD20 therapy with rituximab and the lymphocytes phenotype in patients with rheumatoid arthritis was i...
Saved in:
Main Authors: | Re KA, Marrazza M, Bertani L, Lurati A, Scarpellini M, Bompane D |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/c6faa4f926904747943482ce1ce7ba1c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
by: Lurati A, et al.
Published: (2013) -
Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
by: Lurati A, et al.
Published: (2021) -
Safety of etanercept in elderly subjects with rheumatoid arthritis
by: Alfredomaria Lurati, et al.
Published: (2009) -
Rituximab therapy in Greek patients with rheumatoid arthritis
by: Haralampos M Moutsopoulos, et al.
Published: (2008) -
Update on the use of rituximab for intractable rheumatoid arthritis
by: R John Looney
Published: (2009)